Try a new search

Format these results:

Searched for:

in-biosketch:yes

person:norcll01

Total Results:

186


Increasing cutaneous afferent feedback improves proprioceptive accuracy at the knee in patients with sensory ataxia

Macefield, Vaughan G; Norcliffe-Kaufmann, Lucy; Goulding, Niamh; Palma, Jose-Alberto; Fuente Mora, Cristina; Kaufmann, Horacio
Hereditary sensory and autonomic neuropathy type III features disturbed proprioception and a marked ataxic gait. We recently showed that joint-angle matching error at the knee is positively correlated with the degree of ataxia. Using intraneural microelectrodes, we also documented that these patients lack functional muscle spindle afferents but have preserved large-diameter cutaneous afferents, suggesting that patients with better proprioception may be relying more on proprioceptive cues provided by tactile afferents. We tested the hypothesis that enhancing cutaneous sensory feedback by stretching the skin at the knee joint using unidirectional elasticity tape could improve proprioceptive accuracy in patients with a congenital absence of functional muscle spindles. Passive joint angle matching at the knee was used to assess proprioceptive accuracy in 25 patients with HSAN III and 9 age-matched control subjects, with and without taping. Angles of the reference and indicator knees were recorded with digital inclinometers, and the absolute error, gradient and correlation coefficient between the two sides calculated. Patients with HSAN III performed poorly on the joint angle-matching test (mean matching error +/- SE 8.0 +/- 0.8 degrees , controls 3.0 +/- 0.3 degrees ). Following application of tape bilaterally to the knee in an X-shaped pattern, proprioceptive performance improved significantly in the patients (mean error 5.4 +/- 0.7 degrees ) but not in the controls (3.0 +/- 0.2 degrees ). Across patients, but not controls, significant increases in gradient and correlation coefficient were also apparent following taping. We conclude that taping improves proprioception at the knee in HSAN III, presumably via enhanced sensory feedback from the skin.
PMID: 26655817
ISSN: 1522-1598
CID: 1889812

Brainstem reflexes in familial dysautonomia. Reply to "Evidence of brainstem dysfunction in patients with familial dysautonomia and carriers of the IKBKAP mutation" [Letter]

Gutierrez, Joel V; Norcliffe-Kaufmann, Lucy; Kaufmann, Horacio
PMID: 26529998
ISSN: 1872-8952
CID: 1825872

Mother-induced hypertension in familial dysautonomia

Norcliffe-Kaufmann, Lucy; Palma, Jose-Alberto; Kaufmann, Horacio
Here we report the case of a patient with familial dysautonomia (a genetic form of afferent baroreflex failure), who had severe hypertension (230/149 mmHg) induced by the stress of his mother taking his blood pressure. His hypertension subsided when he learnt to measure his blood pressure without his mother's involvement. The case highlights how the reaction to maternal stress becomes amplified when catecholamine release is no longer under baroreflex control.
PMCID:4742405
PMID: 26589199
ISSN: 1619-1560
CID: 1889822

Autonomic Findings in Takotsubo Cardiomyopathy

Norcliffe-Kaufmann, Lucy; Kaufmann, Horacio; Martinez, Jose; Katz, Stuart D; Tully, Lisa; Reynolds, Harmony R
Takotsubo cardiomyopathy (TC) often occurs after emotional or physical stress. Norepinephrine levels are unusually high in the acute phase, suggesting a hyperadrenergic mechanism. Comparatively little is known about parasympathetic function in patients with TC. We sought to characterize autonomic function at rest and in response to physical and emotional stimuli in 10 women with a confirmed history of TC and 10 age-matched healthy women. Sympathetic and parasympathetic activity was assessed at rest and during baroreflex stimulation (Valsalva maneuver and tilt testing), cognitive stimulation (Stroop test), and emotional stimulation (event recall, patients). Ambulatory blood pressure monitoring and measurement of brachial artery flow-mediated vasodilation were also performed. TC women (tested an average of 37 months after the event) had excessive pressor responses to cognitive stress (Stroop test: p <0.001 vs baseline and p = 0.03 vs controls) and emotional arousal (recall of TC event: p = 0.03 vs baseline). Pressor responses to hemodynamic stimuli were also amplified (Valsalva overshoot: p <0.05) and prolonged (duration: p <0.01) in the TC women compared with controls. Plasma catecholamine levels did not differ between TC women and controls. Indexes of parasympathetic (vagal) modulation of heart rate induced by respiration and cardiovagal baroreflex gain were significantly decreased in the TC women versus controls. In conclusion, even long after the initial episode, women with previous episode of TC have excessive sympathetic responsiveness and reduced parasympathetic modulation of heart rate. Impaired baroreflex control may therefore play a role in TC.
PMID: 26743349
ISSN: 1879-1913
CID: 1901192

Respiratory Characteristics In Patients With Familial Dysautonomia [Meeting Abstract]

Kazachkov, M; Tkachenko, N; Palma, J; Norcliffe-Kaufmann, L; Fefferman, N; Spalink, C; Kothare, S; Kaufman, H
ISI:000390749607143
ISSN: 1535-4970
CID: 2414962

Cutaneous silent period in inherited disorders of decreased pain perception [Meeting Abstract]

Gutierrez, J; Remon, Y; Norcliffe-Kaufmann, L; Leis, A; Kaufmann, H
Objective: To evaluate the cutaneous silent period (CSP) in patients with hereditary sensory and autonomic neuropathies (HSAN) type III (HSAN-III) with decreased pain perception and type IV (HSAN-IV) with complete insensitivity to pain. Background: Decreased pain perception is a cardinal feature of HSAN. The CSP, the electrophysiological equivalent of a withdrawal reflex from a painful stimulus, may help to evaluate A-delta fibers in patients with different types of HSAN. Methods: Twenty patients with HSAN-III, 3 patients with HSAN-IV and 24 age-matched healthy control subjects were evaluated. The CSP was recorded from voluntarily contracted thenar muscles while electrical pulses were given to the second finger at 75 and 90 mA intensities. The percentage of appearance, latency, and duration of CSP responses were quantified. Kruskal-Wallis test was used for between group comparisons. Results: Patients with HSAN-III and control subjects showed 100[percnt] of appearance of CSP for both intensities of stimulation. However, when compared to controls, patients with HSAN-III showed significantly longer latencies (75 mA: 79+/-11 versus 69+/-12, p=0.02; 90 mA: 74+/-8 versus 67+/-11, p=0.0001) and increased durations (75 mA: 54+/-21 versus 32+/-13, p=0.0001; 90 mA: 54+/-12 versus 43+/-17, p=0.04) for the two intensities of stimulation. Patients with HSAN-IV showed no CSP responses at both intensities of stimulation. Conclusions: Relatively preserved, albeit delayed and prolonged, CSP responses in HSAN-III are congruent with the clinical observation that these patients are able to perceive some forms of pain (e.g., sharp pain). We speculate that even a reduced population of A-delta fibers is sufficient to produce CSP in HSAN-III. In contrast, the absence of CSP in HSAN-IV, congruent with complete insensitivity to pain, suggests that these patients have no functional A-delta nociceptive fibers. CSP can be used as an efficient physiologic aid to discriminate between complete insensitivity to pain and dulled pain perception
EMBASE:72251654
ISSN: 0028-3878
CID: 2096602

Progressive retinal structure abnormalities in multiple system atrophy

Mendoza-Santiesteban, Carlos E; Palma, Jose-Alberto; Martinez, Jose; Norcliffe-Kaufmann, Lucy; Hedges, Thomas R 3rd; Kaufmann, Horacio
BACKGROUND: Objective measures of disease progression that can be used as endpoints in clinical trials of MSA are necessary. We studied retinal thickness in patients with MSA and assessed changes over time to determine its usefulness as an imaging biomarker of disease progression. METHODS: This was a cross-sectional study including 24 patients with MSA, 20 with PD, and 35 controls, followed by a longitudinal study of 13 MSA patients. Patients were evaluated with high-definition optical coherence tomography and the Unified Multiple System Atrophy Rating Scale. Evaluations were performed at baseline and at consecutive follow-up visits for up to 26 months. RESULTS: MSA subjects had normal visual acuity and color discrimination. Compared to controls, retinal nerve fiber layer (P = 0.008 and P = 0.001) and ganglion cell complex (P = 0.013 and P = 0.001) thicknesses were reduced in MSA and PD. No significant differences between MSA and PD were found. Over time, in patients with MSA, there was a significant reduction of the retinal nerve fiber layer and ganglion cell complex thicknesses, with estimated annual average losses of 3.7 and 1.8 mum, respectively. CONCLUSIONS: Visually asymptomatic MSA patients exhibit progressive reductions in the thickness of the retinal nerve fiber layer and, to a lesser extent, in the macular ganglion cell complex, which can be quantified by high-definition optical coherence tomography. Specific patterns of retinal nerve fiber damage could be a useful imaging biomarker of disease progression in future clinical trials. (c) 2015 International Parkinson and Movement Disorder Society.
PMCID:4568758
PMID: 26359930
ISSN: 1531-8257
CID: 1772652

Increased frequency of rhabdomyolysis in familial dysautonomia

Palma, Jose-Alberto; Roda, Ricardo; Norcliffe-Kaufmann, Lucy; Kaufmann, Horacio
BACKGROUND: Familial dysautonomia (FD, OMIM# 223900) is an autosomal recessive disease with features of impaired pain and temperature perception and lack of functional muscle spindles. After 3 FD patients presented with rhabdomyolysis in a short time span, we aimed to determine the frequency of rhabdomyolysis is this population. METHODS AND RESULTS: In a retrospective chart review of 665 FD patients, 8 patients had at least 1 episode of rhabdomyolysis. Two patients had 2 episodes. The average incidence of rhabdomyolysis in FD was 7.5 per 10,000 person-years. By comparison, the average incidence with statins has been reported to be 0.44 per 10,000 person-years. Mean maximum creatine kinase (CK) level was 32,714 +/- 64,749 U/l. Three patients had a hip magnetic resonance imaging showing gluteal hyperintensities. CONCLUSIONS: Patients with FD have an increased incidence of rhabdomyolysis. We hypothesize that this may result from a combination of absent functional muscle spindles and muscle mitochondrial abnormalities
PMCID:4596763
PMID: 26202308
ISSN: 1097-4598
CID: 1684012

Chewing-induced hypertension in afferent baroreflex failure: A sympathetic response?

Mora, Cristina Fuente; Norcliffe-Kaufmann, Lucy; Palma, Jose-Alberto; Kaufmann, Horacio
Familial dysautonomia (FD) is a rare genetic disease with extremely labile blood pressure due to baroreflex deafferentation. Patients have marked surges in sympathetic activity, frequently surrounding meals. We conducted an observational study to document the autonomic responses to eating in patients with FD, and to determine whether sympathetic activation was caused by chewing, swallowing or stomach distension. Blood pressure and RR intervals were measured continuously while chewing gum (n = 15), eating (n = 20) and distending the stomach with a percutaneous endoscopic gastrostomy (PEG) tube feeding (n = 9). Responses were compared to those of normal controls (n = 10) and of patients with autonomic failure (n = 10) who have chronically impaired sympathetic outflow. In patients with FD, eating was associated with a marked, but transient pressor response (p<0.0001) and additional signs of sympathetic activation including tachycardia, diaphoresis and flushing of the skin. Chewing gum evoked a similar increase in blood pressure that was higher in patients with FD than in controls (p = 0.0001), but was absent in patients with autonomic failure. In patients with FD distending the stomach with a PEG tube feeding failed to elicit a pressor response. The results provide indirect evidence that chewing triggers sympathetic activation. The increase in blood pressure that is exaggerated in patients with FD due to blunted afferent baroreceptor signalling. The chewing pressor response may be useful as a counter-manoeuvre to raise blood pressure and prevent symptomatic orthostatic hypotension in patients with FD
PMCID:5074388
PMID: 26435473
ISSN: 1469-445x
CID: 1794492

Depression in multiple system atrophy: Impact on quality of life and disease progression [Meeting Abstract]

Martinez, J M; Palma, J A; Norcliffe-Kaufmann, L J; Perez, M; Kaufmann, H
Introduction: Depressive symptoms are common in patients with multiple systematrophy (MSA). We aimed to determine the prevalence of depression in MSA and its impact on quality of life and disease progression. Methods: MSA patients enrolled in a natural history study to determine the natural progression of disease. Patients completed psychiatric (Zung Depression scale, Spielberg's anxiety scale and Body vigilance scale) and autonomic (OHQ, COMPASS, UMSARS-I and II, SCOPA-Autonomic and SF36 Quality of life scale) rating scales, and underwent autonomic and cardiovascular assessments at baseline, and then followed at regular intervals for repeat assessments. Results: Forty-five MSA patients (mean age 61.8 years, 4.3 years disease duration) were included. Thirty patients (67%) scored as having depression on the Zung depression scale (15 mild, 13 moderate, and 2 severe). Seventy-three percent had orthostatic hypotension (OH). Depressed patients had higher trait/state anxiety and body vigilance scores than non-depressed patients. Depressed patients had significantly higher OHQ scores on each of the 6 OHSA items and each of the OHDAS items (OH interference with activities of standing and walking). Trait-anxiety and depression correlated with OHSA and OHDAS items. Depressed patients reported greater OHQscores for the same amount of blood pressure change than non-depressed. Linear regression showed significant effect of depression on progression of UMSARS-II scores. Depression correlated with orthostatic and urinary function symptoms on the COMPASS scale. Conclusions: Depression is common in MSA. It impacts the progression and severity of autonomic symptoms. Recognizing and treating depression may improve quality of life and ameliorate symptoms
EMBASE:72346681
ISSN: 1872-7484
CID: 2204712